How China is battling the chikungunya virus
Killer fish, "cannibal" mosquitoes and drones are just three of the tactics that China is using to fight a new virus.
After thousands of cases of the debilitating chikungunya infection were found across the southern Guangdong province, public health officials have been creative in their efforts to contain it.
'Compulsive killers'
China employed hardline tactics during the Covid-19 pandemic and this time the authorities are using similar "patriotic public health" measures like mass testing, mandatory quarantines, widespread surveillance and citywide lockdowns. But they are also using more novel methods.
The virus is transmitted by infected mosquitoes, so China is using giant "compulsive killers", known as elephant mosquitoes, whose larvae "devour" the Aedes mosquito, which passes chikungunya to people, said The Telegraph.
A single larvae can consume a "staggering" number of mosquito larvae, up to several thousand, according to a paper published last year in the Journal of Tropical Medicine, and their "compulsive killing" and "predatory prowess" extend beyond "direct consumption" – after killing the mosquito larvae they "leave them uneaten".
Mosquitoes aren't the only creatures being used. Researchers at Sun Yat-sen University in Guangdong have "deployed 5,000 larvae-eating fish, which consume the larvae that hatch in the city's lakes".
Insecticide is being widely used and Chinese state television has shown masked soldiers spraying it "around city streets, residential areas, construction sites" and other areas, said The Associated Press.
After "unusually" heavy rain and high temperatures "worsened the crisis", officials began using drones to "try to find standing water, where mosquitoes lay eggs".
Meanwhile, community workers in red vests are going "door to door" to inspect homes, said The New York Times, and, according to local social media, they're ordering residents to empty all containers of water, including water bowls for their dogs.
'Bend over'
The virus was first identified in Tanzania in 1952, and has since spread to 110 countries. It's most commonly found in sub-Saharan Africa, Southeast Asia and South America.
It took its name from a Swahili dialect and translates approximately as "to bend over" – a reference to its debilitating symptoms. It is rarely fatal but it can cause fever, a rash and joint pain. It can also lead to severe illness in vulnerable groups such as newborn babies, the elderly and people with underlying medical conditions.
Another 1,387 cases of chikungunya virus were confirmed in China last week, said the Daily Mail. This took the tally to more than 10,000 cases overall, with infections reported in Taiwan and Hong Kong, Europe and the US. But last week's figure was down on the previous seven-day tally of 2,892 cases, a sign that the outbreak could now be slowing.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
24 minutes ago
- Medscape
Vaccine Skepticism Is Spreading, but You Can Turn the Tide
Vaccines today prevent or significantly reduce the impact of around 30 dangerous and potentially life-threatening diseases. Consistent vaccination programs have been crucial in ensuring that most of these illnesses no longer pose a public health threat, as a large portion of the population is immunized before encountering the infections. Vaccines and vaccination programs thus represent one of the greatest success stories in infectious disease prevention. However, few medical interventions spark as much skepticism in certain populations as vaccination. The specific effects of these doubts — ranging from hesitancy about particular vaccines to outright refusal — are hard to quantify, especially because other factors can also lead to low vaccination rates. For example, conducting vaccination campaigns in crisis or war zones remains challenging, even when sufficient vaccine supplies exist and most eligible people want to be vaccinated. Threat to Infectious Disease Control It is well-established that diseases such as polio and measles could be eradicated through consistent immunization of a sufficiently large segment of the population. Likewise, severe illness among especially vulnerable individuals — who cannot be vaccinated due to medical reasons — can be prevented through herd immunity, thereby reducing individual suffering. Yet, those with skeptical or anti-vaccine views often ignore or deny these facts. Instead, they argue that vaccination is a personal decision to be made solely between the individual and their healthcare provider. In this view, national vaccination plans designed to protect both individuals and the community are given lesser importance. Not Without Consequences In 2019, before the COVID-19 pandemic brought renewed focus to vaccination, the World Health Organization (WHO) identified vaccine skepticism as one of the top 10 global health threats. The WHO defines vaccine skepticism as the 'delayed acceptance or refusal of vaccines despite the availability of vaccination services.' Experts at WHO are particularly concerned that such skepticism threatens to reverse significant progress made in recent decades against vaccine-preventable diseases. Despite numerous efforts to educate the public objectively about vaccines and increase acceptance, vaccine-skeptical views continue to gain influence in societal discourse and among decision-makers worldwide. Social media plays a key role in this trend. Misinformation can spread rapidly and often goes uncorrected, amplifying fears and bringing latent anxieties to the surface. These platforms act as multipliers: Individuals who have long harbored vaccine skepticism find their concerns reinforced by reports of potential dangers from supposedly insufficiently tested new vaccines, while those previously neutral or positive about vaccination become uncertain. Both groups share their fears and false beliefs, fueling further spread within networks of similarly doubtful people. COVID-19 as a Catalyst Vaccine skepticism and opposition are not new — they have existed since the earliest days of vaccination. Edward Jenner, the English country doctor who administered the first smallpox vaccine in 1796, faced resistance despite the widespread acclaim for his discovery. By 1866, the first organized anti-vaccination group, the British 'National Anti-Vaccination League,' had formed. Opponents feared vaccination might cause more harm than good. Caricatures depicting people growing cow heads from their arms after vaccination circulated, and early anti-vaccine publications appeared. Since then, criticism and opposition have accompanied nearly every new vaccine introduced. The COVID-19 pandemic significantly accelerated the spread of anti-vaccine content, acting as a catalyst for alarmist and conspiratorial narratives that had previously remained largely under the public radar. With COVID-19, organized anti-vaccine movements gained unprecedented visibility and influence. The effects have been long-lasting. In vulnerable populations, vaccine myths not only influenced decisions regarding COVID-19 vaccination but also fueled broader skepticism toward vaccines in general. Experts are now exploring ways to reverse this trend. Recent research into modifiable underlying attitudes and concerns across different populations offers promising avenues for intervention. Modifiable Risk Factors A mixed-methods study conducted by doctors and psychologists from the universities of Oxford and Oslo, involving comparable populations from Norway and the UK, identified five key modifiable risk factors associated with COVID-19 vaccine skepticism: The illusion of invulnerability, Doubts about vaccine effectiveness, Distrust of (health) authorities, Downplaying the societal impact of COVID-19, and Health-related fears concerning the vaccine. These risk factors have strong predictive value and can be strategically addressed by public health organizations to reduce vaccine hesitancy. Both vaccine opposition and hesitancy stem largely from misconceptions about the actual risks, benefits, and potential side effects of vaccines and their adjuvants. Most people who remain undecided do not reject vaccines out of firm conviction. There are multiple opportunities to address uncertainties and counter misinformation with well-founded evidence. Traditional educational approaches have proven to be as effective as newer motivational interventions aimed at increasing personal motivation to get vaccinated. Both strategies have helped raise vaccination rates. However, there is still a lack of high-quality studies evaluating the effectiveness of motivational methods in more detail. Can Anti-Vaccine Movements Be Reversed? Anti-vaccine activism is not confined to the general public; even some healthcare professionals are susceptible to vaccine skepticism and may inadvertently contribute to the spread of misinformation — often via the same channels as nonexperts. When such views come from medical professionals, the impact is especially damaging. The high credibility generally afforded to doctors lends greater weight to their vaccine-related statements than those from former classmates or alternative medicine practitioners. The spread of false or biased information about vaccines amounts to an attack on science itself — a reality that many fail to recognize. Medical assessments of vaccines, adjuvants, or new vaccine technologies are sometimes deliberately downplayed or misrepresented to bolster anti-vaccine narratives. These groups use such claims to suggest contradictory scientific opinions on vaccines exist, despite a clear consensus among experts supporting vaccination. Recent developments in the US highlight the dangers of coordinated misinformation. In June, all 17 permanent members of the Advisory Committee on Immunization Practices were dismissed and partially replaced with known vaccine critics and underqualified individuals. Experts have warned that this move severely undermines trust in the committee's future recommendations. It is concerning that even health authorities can fall under the influence of anti-vaccine groups, with real consequences for official vaccine policies. While such scenarios remain unthinkable in Germany and other European countries, it is crucial to proactively resist attempts at influence, counter misinformation, and communicate the scientific basis of vaccine decisions clearly and accessibly. Doctors and healthcare professionals often lack the time to provide detailed information and persuasion to vaccine-skeptical individuals or those unsettled by misinformation. However, in many cases, extensive information isn't necessary — simply highlighting the health benefits of vaccination and directing patients to reliable online resources can be sufficient. For example, the Robert Koch Institute, Berlin, Germany, offers alphabetically organized, easy-to-understand information from the German Standing Committee on Vaccination on each available vaccine, along with answers to frequently asked questions, under the title ' Vaccinations AZ.' Making Vaccines More Accessible Another often overlooked factor in vaccine hesitancy is that missed vaccinations can result from a lack of information, misunderstandings, or simply forgetting appointments. Limited language skills may hinder understanding of vaccine information, while patients might hesitate to ask questions. Multilingual brochures can help by enabling patients to review information at their own pace and raise queries at follow-up visits. In Germany, for example, the current vaccination schedule is available in 10 languages. Physicians can also help reduce missed appointments by setting up automatic reminders via apps, email, or short message service. Since 2025, vaccination records for all insured individuals have been accessible through the digital vaccination pass, unless the individual opts out. Patients can also enroll in personalized vaccination reminder services to stay on schedule.
UPI
25 minutes ago
- UPI
Travel-related chikungunya cases in England climb nearly three-fold
Aug. 14 (UPI) -- The number of travel-related cases of chikungunya, a mosquito-borne viral infection, has nearly tripled in England during the first six months of the year compared to the same period last year, British health officials said Thursday. According to the latest data from the UK Health Security Agency, there have been 73 cases of the virus reported in England between January and June. During the same period in 2024, there were only 27 cases. The health agency said the 73 cases is the highest number recorded in this period to date. The majority of the infected patients had reported traveling to Sri Lanka, India and Mauritius, where there were infections associated with outbreaks in Indian Ocean countries, it said. Chikungunya is transmitted to humans by infected mosquitoes. Severe symptoms and death associated with the virus are rare, but can occur in babies and the elderly, especially those with serious health problems, according to the World Health Organization. Despite its lack of fatality, the disease can still cause fever and joint pain, which the World Health Organization says can be debilitating and prolonged. Other symptoms include joint swelling, muscle pain, headache, nausea, fatigue and rash. Two vaccines have been approved for use in several countries, including Britain. "Chikungunya can be a nasty disease and we're seeing a worrying increase in cases among travelers returning to the UK," Dr. Philip Veal, consultant in Public Health at UKHSA, said in a statement. "While this mosquito-borne infection is rarely fatal, it can causes severe joint and muscle pain, headaches, sensitivity to light and skin rashes. Thankfully, symptoms usually improve within a few weeks, but joint pain may last for months or longer." According to the European Center for Disease Prevention and Control, as of July, there have been 240,000 cases of the virus so far this year and 90 deaths in 16 countries. France has tested positive for 30 cases and Italy for one. However, France's Reunion Island -- located in the Indian Ocean, to the east of Madagascar -- is battling an epidemic of the virus. The Pacific Community, the principal scientific and technical organization supporting development in the Pacific region, said in a statement that the small island has confirmed 54,410 cases of the virus, including 28 deaths, so far this year. "Health authorities are urging heightened vigilance for travelers to La Reunion," SPC said, "visitors are advised to take preventive measures against mosquito bites, including the use of insect repellent, wearing long-sleeved clothing and staying in accommodations with screened windows or air conditioning." Earlier this month, the U.S. Centers for Disease Control and Prevention issued a travel warning for Americans thinking of visiting southern China over an outbreak of chikungunya there. The CDC states there are outbreaks in Bolivia, China's Guangdong Province, Kenya, Madagascar, Mauritius, Mayotte, Somalia and Sri Lanka.
Yahoo
an hour ago
- Yahoo
Vitamin B12 Market Set to Surpass USD 444.47 Million by 2030, Driven by Rising Veganism, Preventive Healthcare Focus, and Growth in Nutraceuticals: MarkNtel Advisors
NEW DELHI, Aug. 14, 2025 /PRNewswire/ -- The Global Vitamin B12 Market is on track to grow from USD 288 million in 2024 to USD 444.47 million by 2030, representing a compound annual growth rate (CAGR) of 7.50%, according to the latest industry research. The market's expansion is being fueled by heightened consumer awareness of Vitamin B12's critical role in human health, alongside a surge in plant-based dietary patterns, and rapid advances in the nutraceutical and fortified food industries. Vitamin B12, scientifically known as cobalamin, is a water-soluble vitamin essential for red blood cell formation, neurological function, and DNA synthesis. Naturally occurring in animal-derived foods such as meat, fish, eggs, poultry, and dairy, it is notably absent from plant-based diets — creating a significant risk of deficiency among vegans, vegetarians, and individuals with certain medical conditions that affect nutrient absorption. Deficiency symptoms can include fatigue, weakness, anemia, cognitive decline, and nerve damage. For An In-Depth Breakdown of Market Trends, Forecasts, and Industry Segmentation, Download Free Sample of the Report Here: Leading Companies in the Vitamin B12 Market: The competitive landscape of the global Vitamin B12 market features a strong mix of top Vitamin B12 companies, trusted brands, and leading manufacturers driving innovation and supply worldwide. Key industry players dominating the Vitamin B12 segment include Hebei Yufeng Group, Hebei Huarong Pharmaceutical, BASF Nutrition, Sanofi, NCPC VICTOR, Chempure, Hebei Yuxing Bio-Engineering Co. Ltd, Ningxia Kingvit Pharmaceutical, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., LUPIN, Mylan N.V., Apotex Inc., Bristol Laboratories Ltd., Mankind Pharma, and Biocon, among others. These companies are recognized for their large-scale production capacities, high-quality formulations, and extensive distribution networks, making them crucial contributors to the growth of the global Vitamin B12 market. Why Vitamin B12 Demand is Rising Globally: Increasing Vitamin B12 Deficiency RatesGlobally, healthcare practitioners are diagnosing Vitamin B12 deficiency in a broader range of demographics than ever before. Causes include dietary restrictions, gastrointestinal disorders, age-related absorption issues, and genetic factors. The rise in deficiencies is driving demand for both preventive and therapeutic supplementation across medical, retail, and online channels. Shift Toward Plant-Based NutritionThe rapid growth in vegan and vegetarian populations, driven by environmental, ethical, and health considerations, is significantly reshaping food and supplement markets. Since plant-based diets naturally lack Vitamin B12, fortified foods such as plant-based milks, breakfast cereals, and nutritional yeast have become important dietary staples. Supplementation is now a critical recommendation for those avoiding animal products. Expansion of the Nutraceutical and Functional Food IndustryThe global nutraceutical market is integrating Vitamin B12 into a wide range of formulations, from energy-boosting blends and cognitive health products to immune support and sports recovery supplements. Increasing disposable incomes and the shift toward proactive wellness are fueling retail growth across supermarkets, pharmacies, and e-commerce platforms. Market Segmentation Analysis By Cyanocobalamin Type: Injection: Preferred in clinical environments for treating severe deficiencies, neurological disorders, and anemia. Known for rapid absorption and effectiveness in acute cases. Oral: Tablets, capsules, and gummies dominate the consumer market due to convenience, affordability, and wide availability. Spray: A growing category for fast absorption, targeting both the wellness and sports nutrition markets. By Application: Medical Treatment: The largest revenue segment, supported by healthcare providers and prescription-based supplementation. Food Additives: Increasing demand in fortified plant-based beverages, cereals, and packaged health foods. Feed Supplements: Critical in the livestock and poultry sectors to improve animal health and productivity. Others: Includes pharmaceutical integration and cosmetic formulations targeting skin health. Access Complete Data Tables, Forecasts, and Competitor Profiles Here: Regional Outlook: Asia-Pacific Leading the Growth: Asia-Pacific is projected to dominate the market due to: High prevalence of malnutrition & B12 deficiency in younger populations. Government-led nutrition awareness campaigns in India, China, and Southeast Asia. Rising disposable incomes driving health supplement purchases. North America and Europe will continue to hold substantial market shares, driven by advanced healthcare infrastructure, preventive medicine adoption, and high supplement penetration rates. Key Market Trends: B12-Fortified Vegan Foods: Rapid innovation in fortified plant-based products to meet the needs of vegan and vegetarian consumers. Digital Health Integration: AI-driven nutrition platforms and telehealth services are increasingly recommending tailored B12 supplementation plans. E-Commerce Dominance: Direct-to-consumer supplement sales are surging, with subscription models improving retention rates. Multi-Nutrient Formulations: Combining Vitamin B12 with other vitamins and minerals for holistic health benefits. Challenges and Industry Responses: While Vitamin B12 is generally considered safe, excessive intake can cause mild side effects, including skin irritation, headaches, and dizziness in sensitive individuals. Certain medical conditions, such as Leber's hereditary optic neuropathy, require caution. Industry leaders are responding by implementing clear dosage labeling, robust consumer education campaigns, and third-party testing for quality assurance. Request Your Custom Vitamin B12 Market Report – Regional or Country Specific – Get tailored insights for your exact target market. Related Questions You May Find Helpful: Q1. What is the current size of the global Vitamin B12 market? A. The market is valued at approximately USD 288 million in 2024 and is projected to reach USD 444.47 million by 2030, growing at a CAGR of around 7.50%. Q2. Who are the top Vitamin B12 manufacturers globally? A. Major players include Hebei Yufeng Group, BASF Nutrition, Sanofi, Merck & Co., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., and Mankind Pharma among others. Q3. Which industries use Vitamin B12? A. Key sectors include pharmaceuticals, nutraceuticals, food & beverage, feed supplements, and cosmetics. Q4. Why is demand for Vitamin B12 increasing? A. Rising veganism, increasing vitamin deficiencies, and higher health awareness are driving global demand. Q5. What are the key benefits of Vitamin B12 supplements? A. Supports blood health, DNA synthesis, nerve function, and helps prevent megaloblastic anemia. Q6. Which region leads the Vitamin B12 market? A. Asia-Pacific dominates due to high deficiency rates, rising incomes, and growing vegan/vegetarian populations. Q7. Where can I get a detailed report? A. MarkNtel Advisors offers in-depth Vitamin B12 market analysis with forecasts, segmentation, and competitive intelligence to help businesses make data-driven decisions. Q8. How can I invest in this market? A. Investors can explore partnerships with leading manufacturers, nutraceutical startups, or distribution networks to capitalize on the growing demand. Discover More Market Insights Like This One! – Global Pet Food Packaging Market Research Report: Forecast (2025-2030) - The Global Pet Food Packaging Market size was valued at around USD 11.34 billion in 2024 and is projected to reach USD 15.48 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.32% during the forecast period, i.e., 2025-30. Global Edible Insects Market Research Report: Forecast (2025-2030) - The Global Edible Insects Market size was valued at around USD 1.36 billion in 2024 and is projected to reach USD 6.23 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 28.87% during the forecast period, i.e., 2025-30. Global Ethnic Food Market Research Report: Forecast (2025-2030) - The Global Ethnic Food Market size was valued at around USD 78.2 billion in 2024 and is projected to reach USD 120.69 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.50% during the forecast period, i.e., 2025-30. Global Craft Beer Market Research Report: Forecast (2025-2030) - The Global Craft Beer Market size was valued at around USD106.4 billion in 2024 and is expected to reach USD179.43 billion by 2030. Global Cargo Drones Market Research Report: Forecast (2025-2030) -The Global Cargo Drones Market size was valued at USD 1.78 Billion in 2024 and is projected to reach USD 9.35 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 36% during the forecast period, i.e., 2025-30. About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others. We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others. Contact Us:MarkNtel AdvisorsOffice No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, IndiaContact No: +91 8719999009Email: sales@ our Website: Source: Logo: View original content: SOURCE MarkNtel Advisors Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
